167 related articles for article (PubMed ID: 27647227)
41. Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children.
Song P; Yu J; Wang M; Chang X; Wang J; An L
Int J Environ Res Public Health; 2017 Apr; 14(5):. PubMed ID: 28448433
[TBL] [Abstract][Full Text] [Related]
42. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
[TBL] [Abstract][Full Text] [Related]
43. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
[TBL] [Abstract][Full Text] [Related]
44. High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis.
Huh JH; Lee KJ; Lim JS; Lee MY; Park HJ; Kim MY; Kim JW; Chung CH; Shin JY; Kim HS; Kwon SO; Baik SK
PLoS One; 2015; 10(11):e0143222. PubMed ID: 26571018
[TBL] [Abstract][Full Text] [Related]
45. Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors?
Almobarak AO; Barakat S; Khalifa MH; Elhoweris MH; Elhassan TM; Ahmed MH
Arab J Gastroenterol; 2014 Mar; 15(1):12-5. PubMed ID: 24630507
[TBL] [Abstract][Full Text] [Related]
46. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
47. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
Lu H; Zeng L; Liang B; Shu X; Xie D
Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
[TBL] [Abstract][Full Text] [Related]
48. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
49. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
50. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase.
López-Suárez A; Guerrero JM; Elvira-González J; Beltrán-Robles M; Cañas-Hormigo F; Bascuñana-Quirell A
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1011-7. PubMed ID: 21915061
[TBL] [Abstract][Full Text] [Related]
51. Dietary sodium and potassium intake in relation to non-alcoholic fatty liver disease.
Choi Y; Lee JE; Chang Y; Kim MK; Sung E; Shin H; Ryu S
Br J Nutr; 2016 Oct; 116(8):1447-1456. PubMed ID: 27725000
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.
Leite NC; Salles GF; Araujo AL; Villela-Nogueira CA; Cardoso CR
Liver Int; 2009 Jan; 29(1):113-9. PubMed ID: 18384521
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Biochemical Predictors in Patients with Type-2 Diabetes Mellitus.
Kabir MA; Uddin MZ; Siddiqui NI; Robi IH; Malek MS; Islam MS; Rahman S; Hossain MS; Mahapatra SK; Alam MJ; Ahmad F; Alam MS; Islam MA
Mymensingh Med J; 2018 Apr; 27(2):237-244. PubMed ID: 29769484
[TBL] [Abstract][Full Text] [Related]
54. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
[TBL] [Abstract][Full Text] [Related]
55. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
56. Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes.
Bi WR; Yang CQ; Shi Q; Xu Y; Cao CP; Ling J; Wang XY
Genet Mol Res; 2014 Aug; 13(3):5880-91. PubMed ID: 25117346
[TBL] [Abstract][Full Text] [Related]
57. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.
Gangarapu V; Ince AT; Baysal B; Kayar Y; Kılıç U; Gök Ö; Uysal Ö; Şenturk H
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):840-5. PubMed ID: 26043290
[TBL] [Abstract][Full Text] [Related]
59. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
60. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.
Mantovani A; Rigolon R; Mingolla L; Pichiri I; Cavalieri V; Salvotelli L; Stoico V; Zoppini G; Bonora E; Targher G
J Diabetes Complications; 2017 Jun; 31(6):1021-1026. PubMed ID: 28254449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
